Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.34 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4330261 | 0.98 | KDM4E (0.48) | KDM4EMAPK1HIF1AMEN1KMT2A | |
| SCHEMBL4324661 | 0.98 | KDM4E (0.48) | KDM4EMAPK1HIF1AMEN1KMT2A | |
| Iodide SCHEMBL30637250 | 0.96 | KDM4E (0.46) | KDM4EMAPK1HIF1AMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL30637247 | 0.96 | KDM4E (0.46) | KDM4EMAPK1HIF1AMEN1KMT2A | |
| SCHEMBL110483 | 0.96 | KDM4E (0.39) | KDM4EMAPK1HIF1AMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL28093970 | 0.94 | KDM4E (0.38) | KDM4EMAPK1HIF1AMEN1KMT2A | |
| SCHEMBL907569 | 0.91 | KDM4E (0.52) | KDM4EMAPK1HIF1AMEN1KMT2A | |
| SCHEMBL59429 | 0.89 | KDM4E (0.56) | KDM4EMAPK1HIF1AMEN1KMT2A | |
| SCHEMBL8775297 | 0.89 | KDM4E (0.56) | KDM4EMAPK1HIF1AMEN1KMT2A | |
| SCHEMBL8775294 | 0.89 | KDM4E (0.56) | KDM4EMAPK1HIF1AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7700540-B2 | Hard surface cleaning composition | THE CLOROX COMPANY (US) | 2010-04-20 | — | — | US | claimed |
| US-20070099816-A1 | Hard Surface Cleaning Composition | THE CLOROX COMPANY | 2007-05-03 | — | — | US | claimed |
| US-20230294380-A1 | Multi-Layer Film, and Multi-Layer Structure In Which Same Is Used | KURARAY CO., LTD. (JP) | 2023-09-21 | — | — | US | disclosed |
| EP-4173822-A1 | MULTI-LAYER FILM, AND MULTI-LAYER STRUCTURE IN WHICH SAME IS USED | Kuraray Co., Ltd. (JP) | 2023-05-03 | — | — | EP | disclosed |
| WO-2021122709-A1 | TEXTILE COATED WITH MALODOR REDUCING POLYMERS | BASF SE (DE) | 2021-06-24 | — | — | WO | disclosed |
| US-10772822-B2 | Molecularly imprinted polymers and their use as antidandruff agents | L'OREAL (FR) | 2020-09-15 | — | — | US | disclosed |
| EP-2938641-B1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | ORÉAL L (FR) | 2016-08-24 | — | — | EP | disclosed |
| WO-2016005693-A1 | STATISTICAL CATIONIC COPOLYMERS, METHOD FOR THEIR SYNTHESIS AND THEIR USE FOR INGREDIENT ENCAPSULATION | ISP INVESTMENTS INC. (US) | 2016-01-14 | — | — | WO | disclosed |
| US-20150342859-A1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | L'OREAL (FR) | 2015-12-03 | — | — | US | disclosed |
| EP-2938641-A1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | L'Oréal (FR) | 2015-11-04 | — | — | EP | disclosed |
| WO-2014102206-A1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | L'OREAL (FR) | 2014-07-03 | — | — | WO | disclosed |
| EP-1460478-A1 | Dry film photoresist | Eternal Technology Corporation (US) | 2004-09-22 | — | — | EP | disclosed |
| EP-1429184-A1 | Functionalized copolymer for photopolymerizable composition | Shipley Company, L.L.C. (US) | 2004-06-16 | — | — | EP | disclosed |
| US-20040063027-A1 | Functional polymer | SHIPLEY COMPANY, L.L.C. | 2004-04-01 | — | — | US | disclosed |
| US-20040063026-A1 | Dry film photoresist | SHIPLEY COMPANY, L.L.C. | 2004-04-01 | — | — | US | disclosed |
| US-20030162123-A1 | Functionalized polymer | SHIPLEY COMPANY, L.L.C. | 2003-08-28 | — | — | US | disclosed |
| EP-1336630-A2 | Functionalized polymer | Shipley Co. L.L.C. (US) | 2003-08-20 | — | — | EP | disclosed |
| EP-0421296-B1 | Polyvinyl ester macromonomer and its uses | KURARAY CO (JP) | 1994-12-14 | — | — | EP | disclosed |
| US-5061761-A | POLYVINYL ESTER MACROMONOMER AND ITS USES | KURARAY CO., LTD. (JP) | 1991-10-29 | — | — | US | disclosed |
| EP-0421296-A2 | Polyvinyl ester macromonomer and its uses | KURARAY CO., LTD. (JP) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10772822-B2 | Molecularly imprinted polymers and their use as antidandruff agents | DNMT1, POLR1C, ETF1 | KDM4E 2166/4885MAPK1 3371/4885HIF1A 3663/4885 |
| US-20150342859-A1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | DNMT1, POLR1C, ETF1 | KDM4E 2166/4885MAPK1 3371/4885HIF1A 3663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.